A Novel Patient Decision Aid for Surgical Treatment Options in Early-Stage Breast Cancer

Description

This is a study to assess the feasibility and acceptability of a novel decision aid (DA) in a newly diagnosed, early-stage breast cancer population. Insights gained from patient feedback and the implementation process will be used to improve the information delivered in the decision aid itself and to plan for a larger scale trial to compare the decision aid to standard of care.

Conditions

Breast Cancer

Study Overview

Study Details

Study overview

This is a study to assess the feasibility and acceptability of a novel decision aid (DA) in a newly diagnosed, early-stage breast cancer population. Insights gained from patient feedback and the implementation process will be used to improve the information delivered in the decision aid itself and to plan for a larger scale trial to compare the decision aid to standard of care.

A Novel Decision Aid for Early Stage Breast Cancer Patients Choosing Between Lumpectomy and Mastectomy: a Pilot Study

A Novel Patient Decision Aid for Surgical Treatment Options in Early-Stage Breast Cancer

Condition
Breast Cancer
Intervention / Treatment

-

Contacts and Locations

Aurora

Universtiy of Colorado Hospital, Aurora, Colorado, United States, 80045

Denver

UCHealth Cherry Creek Medical Center, Denver, Colorado, United States, 80206

Highlands Ranch

UCHealth Highlands Ranch Hospital, Highlands Ranch, Colorado, United States, 80129

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Adult women age 18-100
  • * English speaking
  • * Clinical stage 0-III breast cancer
  • * Eligible for both lumpectomy and mastectomy
  • * Prior surgical consultation regarding treatment options for breast cancer
  • * Previous history of breast cancer
  • * Requires neoadjuvant chemotherapy prior to surgical intervention

Ages Eligible for Study

18 Years to 100 Years

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Colorado, Denver,

Sarah Tevis, MD, PRINCIPAL_INVESTIGATOR, University of Colorado, Denver

Study Record Dates

2027-03